Global Urology and Pelvic Health Market is forecasted to witness a CAGR of 8% by 2027
Urology and pelvic health is a medical and surgical specialty involving disorders of the genitourinary tract and the adrenal glands. Urologists addresses the conditions affecting kidneys, ureters, bladder, and urethra in both men and women. The global urology and pelvic health market is segmented on the basis of product, application, and end-user.
Technological Innovations and Developments in the Urology and Pelvic Health Market
Recent advancements, innovations and developments in the urology and pelvic health market have enabled manufacturers to develop efficient medical products with excellent capabilities such as minimally invasive approach, fast recovery and reduced healthcare infections. All top companies axcross the world have recently launched their advanced medical products to expand their geographic reach and dominate their position in the urology and pelvic health market.
Some
of the technological advancements are listed below:
- In November 2022, Teleflex launched its UroLift System in India, a minimally invasive approach for the treatment of benign prostatic hyperplasia (BPH) or prostate enlargement providing a rapid symptomatic relief for men allowing quick recovery.
- In November 2022, Coloplast launched SpeediCath Flex Set, a new catheter in the US market, featuring a triple action coating technology specifically designed to reduce the risk of Urinary Tract Infections (UTIs) and urethral damage.
- In September 2022, Olympus Corporation launched its VISERA ELITE III Surgical Visualization Platform that support imaging functions and minimally invasive therapies, to address the needs of healthcare professionals for endoscopic procedures including urology.
Heavy Investments by Market Companies in the Urology and
Pelvic Health Market to Trigger the Product Development
From a geographical outlook, North America is poised to hold a larger market share in the urology and pelvic health market. This can be mainly attributed to the investments made by hospitals to procure the advanced medical devices for urology and pelvic health, favorable reimbursement policies and fully developed healthcare infrastructures.
Competitive
Landscape Analysis: Urology and Pelvic
Health Market
The global urology and pelvic health market is marked by the presence
of well-established market companies such as listed below: -
- Boston Scientific Corporation (US)
- Medtronic plc (Ireland)
- Coloplast (Denmark)
- B. Braun Melsungen AG (Germany)
- ConvaTec Group (UK)
- Hollister Incorporated (US)
- Teleflex Inc. (US)
- Stryker Corporation (US)
- Ethicon (US)
Comments
Post a Comment